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Abstract
Background/Aims: Recent studies have indicated that CD38 gene deficiency results in
dedifferentiation or transdifferentiation of arterial smooth muscle cells upon atherogenic
stimulations. However, the molecular mechanisms mediating this vascular smooth muscle
(SMC) phenotypic switching remain unknown. Methods & Results: In the present study, we
first characterized the phenotypic change in the primary cultures of coronary arterial myocytes
(CAMs) from CD38-/- mice. It was shown that CD38 deficiency decreased the expression
of contractile marker calponin, SM22α and α-SMA but increased the expression of SMC
dedifferentiation marker, vimentin, which was accompanied by enhanced cell proliferation.
This phenotypic change in CD38-/- CAMs was enhanced by 7-ketocholesterol (7-Ket), an
atherogenic stimulus. We further found that the CD38 deficiency decreased the expression and
activity of nuclear factor E2-related factor 2 (Nrf2), a basic leucine zipper (bZIP) transcription
factor sensitive to redox regulation. Similar to CD38 deletion, Nrf2 gene silencing increased
CAM dedifferentiation upon 7-Ket stimulation. In contrast, the overexpression of Nrf2 gene
abolished 7-Ket-induced dedifferentiation in CD38-/- CAMs. Given the sensitivity of Nrf2 to
oxidative stress, we determined the role of redox signaling in the regulation of Nrf2 expression
and activity associated with CD38 effect in CAM phenotype changes. It was demonstrated that
in CD38-/- CAMs, 7-Ket failed to stimulate the production of O2-., while in CD38+/+ CAMs 7-Ket
induced marked O2-. production and enhancement of Nrf2 activity, which was substantially
attenuated by NOX4 gene silencing. Finally, we demonstrated that 7-Ket-induced and NOX4dependent O2-. production was inhibited by 8-Br-cADPR, an antagonist of cADPR or NED-19,
an antagonist of NAADP as product of CD38 ADP-ribosylcyclase, which significantly inhibited
the level of cytosolic Ca2+ and the activation of Nrf2 under 7-Ket. Conclusion: Taken together,
these results suggest that CD38 activity is required for 7-Ket-induced Ca2+ and consequently
O2-. production in CAMs, which increases Nrf2 activity to maintain their differentiated status.
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When CD38 gene expression and function are deficient, the Nrf2 activity is suppressed,
thereby leading to phenotypic switching of CAMs.
Copyright © 2015 S. Karger AG, Basel
Introduction

Although vascular smooth muscle cells (VSMCs) undergo remarkable phenotypic
switching during development and progression of vascular diseases such as atherosclerosis
[1], the mechanism mediating this phenotypic changes of VASMCs remain poorly understood.
Recent studies have indicated that CD38 is a multifunctional enzyme responsible for the
production and metabolism of cyclic ADP-ribose (cADPR) and nicotinic acid adenine
dinucleotide phosphate (NAADP) in a variety of mammalian cells including VSMCs, which
play important roles in the regulation of vascular function [2-4]. In particular, this CD38mediated signaling pathway has been implicated in the regulation of cell differentiation
of stem cell or tumor cell behaviors [5-6]. More recently, we demonstrated that the CD38
deficiency decreased contractile phenotype in CAMs and increased collagen deposition
in coronary arterial wall from mice exposed to the high-fat Western diet [2]. It has been
suggested that CD38 signaling pathway may play a critical role in the maintenance of the
contractile phenotype in CAMs. However, it remains unknown how CD38 signaling pathway
works to mediate this phenotypic change in CAMs.
Nuclear factor erythroid 2-related factor 2 (Nrf2), a basic leucine zipper transcription
factor, plays a critical role in protecting cells from oxidative stress [7]. Some recent studies
have reported that Nrf2 could be a new therapeutic target to prevent atherosclerosis [811]. Given previous reports that CD38 importantly controls NOX4-mediated intracellular O2production in CAMs [12], it is likely that a redox-sensitive Nrf2 activity may be suppressed by
deficient expression and function of CD38 and that Nrf2 may serve as a signaling mechanism
to participate in phenotypic switching of CAMs when CD38 gene is lost or deficiently
expressed.
To test this hypothesis, the present study used the primary cultures of CAMs to confirm
that genetic deficiency of CD38 results in the switching of differentiated phenotype into
atherogenic status in CAMs as shown by upregulation of dedifferentiated markers, enhanced
proliferation, and production of extracellular matrix (ECM) proteins. This phenotypic
switching was enhanced by 7-ketocholesterol (7-Ket), a prototype atherogenic stimulus
abundant in oxidized low density lipoprotein (ox-LDL). Then, we went on to reveal that
nucleus Nrf2 protein expression and activity are inhibited by the genetic deficiency of CD38
and that this inhibition of Nrf2 expression and activity contributes to the effect of CD38
deficiency in phenotype switching of CAMs. Lastly, we demonstrated that the mechanisms
underlying Nrf2 inhibition in CAMs lacking CD38 gene are dependent upon NOX4-associated
redox regulation.
Materials and Methods

Isolation and culture of mouse CAMs
CAMs were isolated from mice as previously described [13]. In brief, mice were deeply anesthetized
with an intraperitoneal injection of pentobarbital sodium (25 mg/kg). The heart was excised with an intact
aortic arch and immersed in a petri dish filled with ice-cold Krebs-Henseleit (KH) solution (in mM: 20
HEPES, 128 NaCl, 2.5 KCl, 2.7 CaCl2, 1 MgCl2, 16 glucose, pH 7.4). A 25-gauge needle filled with Hank’s
buffered saline solution (HBSS) (in mM: 5.0 KCl, 0.3 KH2PO4, 138 NaCl, 4.0 NaHCO3, 0.3 Na2HPO4·7H2O,
5.6 D-glucose, and 10 HEPES, with 2% antibiotics mixtue) was inserted into the aortic lumen, while the
whole heart remained in the ice-cold HBSS. The tip of the needle was inserted deep into the heart that
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Mice
Mice were purchased from the Jackson Laboratory. Eight-week old male and female mice were used in
all experiments. All experimental protocols were reviewed and approved by the Institutional Animal Care
and Use Committee of the Virginia Commonwealth University.
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is approximate to the aortic valve. Then, the needle was tied in place with the needle tip as close to the
base of the heart as possible. The infusion pump was started with a 20-ml syringe containing warm HBSS
through an intravenous extension set at a rate of 0.1 ml/min for 15 min. HBSS was replaced with a warm
enzyme solution (1 mg/ml collagenase type I, 0.5 mg/ml soybean trypsin inhibitor, 3% BSA, and 2%
antibiotic-antimycotic mixture), which was flushed through the heart at a rate of 0.1 ml/min. Perfusion
fluid was collected at 30-, 60-, and 90-min of perfusion. At 90 min, the heart was cut with scissors and
the apex was opened to flush out the cells that collected inside the ventricle. The fluid was centrifuged at
1,000 rpm for 10 min, the cell-rich pellets were mixed with the one of the media described below, and the
cells were plated on 2% gelatin-coated six-well plates and incubated in 5% CO2-95% O2 at 37°C. DMEM
supplemented with 10% FBS, 10% mouse serum, and 2% antibiotics was used to culture isolated smooth
muscle cells. The medium was replaced three days after cell isolation and then once or twice each week until
the cells grew to confluence. As previously described [12], mouse CAMs were identified according to their
morphology, immunohistological staining or Western blot analysis of marker proteins, and flow cytometric
characteristics.
Western blot analysis
Western blot analysis was performed as we described previously [14]. In brief, proteins from the
CAMs were extracted using sucrose buffer (20 mM HEPES, 1mM EDTA, 255 mM sucrose, cocktail o protease
inhibitors (Roche), pH 7.4]. Nuclear protein was extracted from CAMs using a Cayman’s Nuclear Extraction
Kit (Cayman 10009277) according to the manufacturer’s instruction. After boiling for 5 minutes at 95°C in
a 5× loading buffer, 30 μg of total proteins were separated by a 12% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). The proteins of these samples were then electrophoretically transferred
at 100 V for 1 hour onto a PVDF membrane (Bio-Rad, USA). The membrane was blocked with 5% nonfat
milk in Tris-buffered saline with Tween 20. After washing, the membrane was probed with 1:1000 dilution
of primary mouse or rabbit antibodies against vimentin (Santa Cruz), calponin (Santa Cruz), proliferating
cell nuclear antigen (PCNA, Cell Signaling), smooth muscle 22 alpha (SM22α, Abcam), α-smooth muscle
ctin (α-SMA, Abcam), Nrf2 (Santa Cruz), NOX1 (Abcam), NOX4 (Santa Cruz), β-actin (Santa Cruz), or
LamB1(Abcam) overnight at 4°C followed by incubation with horseradish peroxidase-labeled IgG (1:5000)
against primary antibodies. The immuno-reactive bands were detected by chemiluminescence methods and
visualized on Kodak Omat X-ray films. Densitometric analysis of the images obtained from X-ray films was
performed using the Image J software (NIH).

Measurement of Nrf2 activity
Nrf2 activity was measured by an Nrf2 transcription factor assay kit (Cayman, 600590) according to
the manufacturer’s instruction. Cayman’s Nrf2 transcription factor assay is a non-radioactive, colorimetric
method for detecting specific transcription factor DNA binding activity in nuclear extracts. A specific double
stranded DNA (dsDNA) sequence containing the Nrf2 response element is immobilized onto the wells of a
96-well plate. Nrf2 contained in nuclear extract samples will bind specifically to the Nrf2 response element.
Nrf2 can be detected by addition of a specific Nrf2 antibody. A secondary antibody conjugated to HRP is
added to provide a sensitive colorimetric readout at 450 nm. Nrf2 activity was expressed as the fold change
of the treatment group versus the control.
Immunofluorescent staining
CAMs on a 8-well chamber slide were fixed with 4% paraformaldehyde (PFA) and then incubated with a
blocking solution of 0.1% Triton X-100 in 5% bovine serum albumin (BSA). This was followed by incubation
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Proliferation assay
The proliferation of CAMs was quantified using an Aqueous One Solution Cell Proliferation Assay kit
(Promega) according to the manufacturer’s instruction as we previously described [15]. Cells were cultured
in a 96-well plate (2,000 cells per well) with or without treatment as indicated. After 48 hours, cells were
incubated with 20 µL Aqueous One Solution for 60 min at 37°C. Then, the absorbance (at 490 nm) of each
sample was measured using a microplate reader. Calibration curves showed the fluorescence reading to be
proportional to the cell number. The proliferation rate was obtained by calculating the fold change in the cell
number of each sample before and after 48-hour incubation.
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with anti-α-SMA (1:200, Abcam) or anti-Nrf2 (1:200, SantaCruz) primary antibody at 4°C overnight. After
washing with phosphate-buffered saline containing 0.1% Tween-20 (PBST) three times, the slides were
incubated with Alexa-555 secondary antibody (Life Technologies) for 1 hour at 37°, and then mounted
in Vector shield mounting medium with DAPI (Vector Laboratories Inc.). Staining was visualized through
sequential scanning on an Olympus laser scanning confocal microscope (Fluoview FV1000, Olympus, Japan)
or fluorescentmicroscopy (BX41TF, Olympus, Japan).

RNA interference
Small interference RNAs (siRNAs) were commercially available (QIAGEN, CA), and the sequences were
as follows: For NOX1 siRNA: 5′-UGG AGU CAC UCC AUU UGC AUC GAUA-3′; for NOX4 siRNA: 5′-UUU AGG
GAC AGC CAA AUG AGC AGGC-3′. Nrf2 siRNA were purchased from Santa Cruz (sc-37049). siRNAs of NOX1,
NOX4 and Nrf2 have been demonstrated to efficiently inhibit the protein expression of NOX1, NOX4 and
Nrf2 as we recently described [12, 16]. A scrambled small RNA (5′-AAU UCU CCG AAC GUG UCA CGU-3′)
was also confirmed no silecung of genes and used as a control in the present study. Transfection of siRNA
was performed using the siLentFect Lipid Reagent (Bio-Rad, CA, USA) according to the manufacturer’s
instructions, and the efficiency of siRNA to silence different genes were confirmed with Western blot
analysis.

Electron spin resonance (ESR) detection of O2For detection of the O2·- production dependent on NADPH oxidase (NOX) in the membrane, CAMs were
gently collected and resuspended in modified Krebs-Hepes buffer containing deferoximine (100 μmol/L;
Sigma, St. Louis, MO, USA) and diethyldithiocarbamate (5 μmol/L; Sigma). These mixtures containing 1×106
cells were subsequently mixed with 1 mM of the O2·-.-specific spin trap, 1-hydroxy-3- methoxycarbonyl2,2,5,5-tetramethylpyrrolidine (CMH) in the presence or absence of manganese-dependent superoxide
dismutase (SOD) (200 U/ml; Sigma). The mixtures were then loaded into glass capillaries and immediately
analyzed for O2·- formation kinetics for 10 min in a Miniscope MS200 ESR spectrometer (Magnettech Ltd.,
Berlin, Germany) as described [12]. The ESR settings were as follows: biofield, 3350; field sweep, 60 G;
microwave frequency, 9.78 GHz; microwave power, 20 mW; modulation amplitude, 3 G; 4096 points of
resolution; receiver gain, 50 for cells. The SOD-sensitive O2·- was calculated as specific signal of NOX activity.
The results were expressed as the fold change of the treatment group versus the control.

Fluorescent microscopic measurement of [Ca2+]i in CAMs
A fluorescence image analysis system was used to determine [Ca2+]i in CAMs with fura-2 acetoxymethyl
ester (fura-2) as an indicator as previously described [14], Having been loaded with 10 μM fura-2 at room
temperature for 30 min, the cells were washed three times with Ca2+-free Hank’s buffer. The ratio of fura-2
emissions, when excited at the wavelengths of 340 and 380 nm, was recorded with a digital camera (Nikon
Diaphoto TMD Inverted Microscope). Metafluor imaging and analysis software were used to acquire, digitize,
and store the images for off-line processing and statistical analysis (Universal Imaging). The fluorescence
ratio of excitation at 340 nm to that at 380 nm (F340/F380) was determined after background subtraction,
and [Ca2+]i was calculated by using following equation: [Ca2+]i = Kdβ[(R − Rmin)/(Rmax − R)], where Kd for the
fura-2-Ca2+ complex is 224 nM; R is the fluorescence ratio (F340/F380); Rmax and Rmin are the maximal and
minimal fluorescence ratios measured by addition of 10 μM of Ca2+ ionophore ionomycin to Ca2+-replete
solution (2.5 mM CaCl2) and Ca2+-free solution (5 mM EGTA), respectively; and β is the fluorescence ratio at
380-nm excitation determined at Rmin and Rmax, respectively.
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Nucleofection of CD38 cDNA and Nrf2 cDNA
Both CD38 cDNA (Catalog# MG204265) and Nrf2 cDNA plasmids (Catalog# MG226717) were
purchased from OriGene Technologies. Transfection of plasmids was performed using a 4D Nucleofector
X-Unit (Lonza, CA, USA) according to the manufacturer’s instructions, which was described in our recent
studies [2]. Briefly, CAMs were trypsinized and centrifuged at 90×g for 10 minutes. The cell pellet was
resuspended in 100 µL P1 Nucleofection solutions (Lonza) for Nucleofection (with the program code
CM137). The program was chosen based on the fact that Nucleofection efficiency was over 80% as analyzed
by flow cytometry using control GFP plasmids. For each Nucleofection sample, 2 µg plasmid DNA was added
in 100 µL P1 Nucleofection solution. After Nucleofection, the cells were cultured in the DMEM medium for
24 hours and then were ready for treatment. The efficiency of CD38 cDNA and Nrf2 cDNA transfection was
assessed by Western blot analyses [17].
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Statistics
Data are presented as means ± SE. Significant differences between and within multiple groups were
examined using ANOVA for repeated measures, followed by Duncan’s multiple-range test. The Student’s
t test was used to detect significant differences between two groups. P<0.05 was considered statistically
significant.

Results

Fig. 1. Phenotypic
characterization in
CD38-/- CAMs. CAMs
from CD38+/+ and
CD38-/- mice were
treated with atherogenic stimulus, 7-ketocholesterol (7-Ket,
10 µg/ml) for 24
hours. Representative Western blot
gel documents and
summarized
data
showing the protein
expression of calponin (A), SM22α (B),
vimentin (C), and
PCNA (D). (E) Typical representative
fluorescent images
for α-SMA staining.
(F)
Summarized
data showing the
proliferation
rate
of CAMs in CD38+/+
and CD38-/- CAMs.
*
P<0.05,
CD38+/+
treated vs. CD38+/+
control; # P<0.05,
CD38+/+ vs. CD38-/CAMs (n=6).
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Phenotypic characterization in CD38-/- CAMs
A hallmark feature of VSMC phenotypic switching is featured by altered expression of
VSMC selective contractile genes, including calponin, SM22α and α-SMA [18]. To examine
whether CD38 regulates phenotypic switching in CAMs, CD38 gene knockout (CD38-/-) CAMs
were used to compare with wild-type (CD38+/+) CAMs. As showed in Fig. 1A and 1B, the
CD38 deficiency significantly decreased the protein level of calponin and SM22α, which
was enhanced by 7-Ket in CAMs. Representative fluorescent images in Fig. 1E also showed
that the fluorescent intensity of a contractile phenotype marker α-SMA decreased in CD38-/CAMs compared with that in CD38+/+ CAMs, particularly when they were treated with 7-Ket.
Conversely, the decrease of proteins associated with the contractile phenotype was
generally accompanying by the increased dedifferentiation marker vimentin in CD38-/- CAMs
(Fig. 1C). The levels of PCNA, an excellent marker for cell proliferation, also increased in
CD38-/- CAMs under control and 7-Ket stimulation when compared with that from CD38+/+
CAMs (Fig. 1D). As shown in Fig.1F, the proliferation rate of CAMs measured using an Aqueous
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Fig. 2. CD38 deficiency
inhibited the activation
of Nrf2. Representative
Western blot gel documents and summarized data showing the
protein expression of
nuclear Nrf2 in CD38/and CD38+/+ CAMs
(A) or CD38-/- CAMs
transfected CD38 cDNA
plasmids (B). (C) Typical
representative
fluorescent images for
nuclear translocation of
Nrf2. DAPI were used as
a nuclear staining marker. (D) Summarized
data showing nuclear
Nrf2 activity of CAMs.
*
P<0.05, CD38+/+ treated vs. CD38+/+ control;
#
P<0.05, CD38+/+ vs.
CD38-/- CAMs (n=6).

Fig. 3. Efficiency of Nrf2
siRNA and cDNA transfection. Representative
Western blot gel documents and summarized
data showing the protein expression of Nrf2
after the transfection
with Nrf2 siRNA (A) and
cDNA(B). *P<0.05, vs.
Scramble control (n=6).

CD38 deficiency inhibited the activation of Nrf2
To gain further insights into the molecular mechanisms underlying the phenotypic
switching due to lack of CD38 in CAMs, the possible involvement of transcription factor,
Nrf2 was examined as a downstream regulator. Since Nrf2 activation is dependent on its
translocation in nuclei to activate expression of its target genes, we first attempted to
examine the nuclear accumulation of Nrf2 protein. As showed in Fig. 2A, the nuclear Nrf2
protein level dramatically decreased in CD38-/- CAMs compared with CD38+/+ CAMs under
7-Ket treatment. In contrast, CD38 overexpression by transfection of CD38 full length cDNA
restored the protein level of nuclear Nrf2 in CD38-/- CAMs (Fig. 2B).
The nuclear translocation of Nrf2 from cytosol under 7-Ket was confirmed by
immunolocalization of anti-Nrf2 antibody using Fluorescent microscopy (Fig. 2C). The assay
of Nrf2 activity was performed using Cayman’s Nrf2 transcription factor assay kit. As shown
in Fig. 2D, the nuclear Nrf2 activity was dramatically decreased in CD38-/- CAMs under 7-Ket
stimulation. All these data strongly suggest that the activation of Nrf2 upon 7-Ket stimulation
is dependent on the normal expression of CD38 gene.
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One Solution Cell Proliferation Assay kit markedly increased in CD38-/- CAMs compared to
CD38+/+ cells, which enhanced by 7-Ket (Fig. 1F).
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Fig. 4. Nrf2 deficiency
changed the phenotypic marker in CAMs.
CD38+/+ CAMs were
transfected with Nrf2
siRNA under the treatment with 7-Ket for
24 hours. Representative Western blot gel
documents and summarized data showing
the protein expression
of calponin (A), SM22α
(B), vimentin (C), and
PCNA (D). (E) Typical
representative fluorescent images for α-SMA
staining. (F) Summarized data showing the
proliferation rate of
CAMs in CD38+/+ and
CD38-/- CAMs. *P<0.05
vs. Scramble control;
#
P<0.05 vs. Scramble
7-Ket (n=6).

The effect of NOX4 gene silencing on Nrf2 translocation into the nucleus
We demonstrated that CD38 importantly controls NAD(P)H oxidase-mediated
intracellular O2·-production in CAMs[12]. Here, we found that NOX4 protein expression
decreased in CD38-/- CAMs compared with CD38+/+ CAMs (Fig. 6A). However, there was no
significant difference in NOX1 protein expression between CD38-/- and CD38+/+ CAMs under
control and 7-Ket treatment (Fig. 6B). By using the ESR spectrometry, we further determined
that 7-Ket markedly induced O2- production, which was almost blocked in CD38-/- CAMs (Fig.
6C). We demonstrated that NOX1 and NOX4 siRNA inhibit the protein expression of NOX1
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Nrf2 deficiency changed the phenotypic marker in CAMs
To elucidate the role of Nrf2 on phenotypic switching in CAMs, we next examined whether
CAMs lacking Nrf2 exhibit a more proliferative status. Nrf2 siRNA was transfected into CAMs
and the phenotypic markers described above were observed. We have demonstrated that
Nrf2 siRNA inhibit the protein expression of Nrf2 by 57.4% (Fig. 3A). As showed in Fig. 4A
and 4B, Nrf2 deficiency resulted in a significant decrease in the protein level of calponin
and SM22α as well as in α-SMA fluorescent staining under 7-Ket stimulation (Fig. 4E).
Conversely, 7-Ket-induced vimentin expression and PCNA were further augmented in CAMs
with silencing of Nrf2 gene (Fig. 4C and 4D), accompanied with an increase in proliferation
rate of CAMs in response to 7-Ket stimulation (Fig. 4F).
To further confirm the Nrf2 on phenotypic change in CAMs, Nrf2 full length cDNA
plasmids were transfected into CD38-/- CAMs. We have demonstrated that Nrf2 cDNA
increased the protein expression of Nrf2 by 2.42-fold (Fig. 3B). As showed in Fig. 5A-F,
Nrf2 overexpression restored the expression of phenotypic markers and cell proliferation
observed in CD38-/- CAMs. These results suggest that Nrf2 determines the proliferative
phenotype in CD38-/- CAMs.
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Fig. 5. Nrf2 deficiency changed the
phenotypic marker
in CAMs. CD38-/CAMs were transfected with Nrf2
cDNA plasmids under the treatment
with 7-Ket for 24
hours. Representative Western blot
gel documents and
summarized data
showing the protein
expression of calponin (A), SM22α (B),
Vimentin (C), and
PCNA (D). (E) Typical representative
fluorescent images
for α-SMA staining.
(F)
Summarized
data showing the
proliferation
rate
of CAMs in CD38/transfected with
Nrf2 cDNA. *P<0.05,
vs. Scramble control;
#
P<0.05, vs. scramble 7-Ket (n=6).

and NOX4 by 66.5% and 77.4%, respectively [12]. Here we found that NOX4 siRNA, not NOX1
siRNA significantly inhibited O2- production induced by 7-Ket (Fig. 6D).
In addition, using fluorescent microscopy we found that Nrf2 translocation decreased
in CAMs transfected with NOX4 siRNA (Fig. 6E). Similarly, Nrf2 activity was also significantly
inhibited in CAMs transfected with NOX4 siRNA (Fig. 6F). Taken together, these results
clearly indicate that NOX4-dependent O2-. production controls Nrf2 activation.
Contribution of cADPR or NAADP-sensitive Ca2+ signaling to O2- production
CD38 functions as a multifunctional enzyme that produces cADPR and NAADP, potent
intracellular Ca2+ mobilizers [4]. To demonstrate the effect of CD38-dependent Ca2+ signaling
on the elevation of O2- and subsequently Nrf2 nuclear translocation, we incubated CAMs with
cADPR antagonist, 8-Br-cADPR, or NAADP antagonist, NED-19 which significantly inhibited
the level of cytosolic Ca2+ under 7-Ket (Fig. 7A and B). Importantly, Fig. 7C showed that 8-BrcADPR or NED-19 significantly inhibited 7-Ket-induced NOX-dependent O2- production.
We also observed nuclear translocation of Nrf2 and Nrf2 activity in 7-Ket-treated cells,
which were inhibited in the presence of 8-Br-cADPR or NED-19 (Fig. 7D, E). These results
demonstrate the role of cADPR or NED-19 -sensitive Ca2+ signaling in the control of O2production, which contributes to the activation of Nrf2.

In the present study, we provided novel evidences that a redox-sensitive transcription
factor, Nrf2 plays an important role in 7-Ket stimulated phenotypic switching of CAMs
(see working model in Fig. 8). This Nrf2-mediated action is critical for the occurrence of
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proliferative and atherosclerotic phenotype when CD38 gene was silenced or deleted.
Furthermore, we confirmed that CD38-derived enzyme product cADPR and NAADP and
associated Ca2+ signaling mechanisms are importantly implicated in the control of Nrf2
activation through NOX4-dependent O2·- production.
The arterial SMCs within atherosclerotic lesions undergo phenotypic modulation
and migration into the intima, where they proliferate, produce extracellular matrix, and
participate in fibrous cap formation [19]. However, the mechanisms that control arterial SMC
phenotypic switching remain poorly understood. In a previous study, we have demonstrated
that CAMs from CD38-/- mice had an enhanced dedifferentiated phenotype upon atherogenic
stimulations compared to that from CD38+/+ mice [2]. In the present study, we also
demonstrated increased expression of dedifferentiation markers and decreased expression
of contractile phenotype markers in CD38-/- CAMs under atherogenic stimulations. These
results in vivo and in vitro strongly indicate that CD38 is a critical enzyme for the control of
CAMs phenotype during atherosclerotic lesions. It is imperative to explore the molecular
mechanisms by which CD38-mediated signaling controls phenotype changes in CAMs.
It was shown that CD38 gene deletion decreased the expression of Nrf2 and reduced
nuclear Nrf2 activity and translocation in CAMs upon atherogenic stimuli. This for the first
time links CD38 and Nrf2 in CAMs, suggesting that Nrf2 is involved in pathological changes
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Fig. 6. NOX4-dependend O2-. is
responsible for
Nrf2 translocation into the
nucleus. Representative Western blot gel
documents and
summarized
data showing the
protein expression of NOX4 (A)
and NOX1 (B)
in CD38+/+ and
CD38-/- CAMs treated with 7-Ket.
(C) Summarized
ESR data showing the relative
O2.- production
in CD38+/+ and
CD38-/- CAMs under control and
treatment with
7-Ket. *P<0.05,
CD38+/+ treated
vs. CD38+/+ control; # P<0.05,
CD38+/+ vs. CD38
- /CAMs. (n=6). (D) Summarized ESR data showing the relative O2.- production (SOD sensitive O2.-) in CD38+/+
CAMs transfected with NOX4 siRNA and NOX1 siRNA. (E) Typical representative fluorescent images for nuclear translocation of Nrf2 in CAMs transfected with NOX4 siRNA. (D) Summarized data showing nuclear
Nrf2 activity of CAMs transfected with NOX4 siRNA. *P<0.05, vs. Scramble control; # P<0.05, vs. Scramble
7-Ket (n=6).
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Fig. 7. cADPR or NAADP-sensitive Ca2+ regulates O2-. Production. CAMs were pretreated with 8-Br-cADPR (30 µM)
or NED-19 (10 µM) and then
stimulated with 7-Ket for 24
hours. Representative Ca2+
traces (A) and summarized
data (B) showing the level of
cytosolic Ca2+ in CAMs. (C)
Summarized ESR data showing the relative O2-. production in CAMs before and after
treatment with 8-Br-cADPR
or NED-19. (D) Typical representative fluorescent images
showing nuclear translocation of Nrf2 in CAMs pretreated
with 8-Br-cADPR or NED-19.
(E) Summarized data showing
nuclear Nrf2 activity in CAMs
pretreated with 8-Br-cADPR
or NED-19. *P<0.05, vs. control; #P<0.05, vs. CAMs treated
with 7-Ket (n=6).

in different vascular cells during atherosclerosis. Recently, it has been reported that geraniol
dietary or ellagic acid protects against atherosclerosis by Nrf2 activation in diet-induced
experimental atherosclerosis [8, 20, 21]. In addition, shear force on arterial endothelial
cells strongly activated Nrf2 and induced its nuclear translocation, thereby promoting
athero-protective gene expression and related endothelial adaptation [11, 22]. However,
there are some reports that disruption of Nrf2 exhibited significantly smaller plaque area
in ApoE-mediated atherosclerosis in mice due to upregulation of CD36 [23]. It seems that
the activation of Nrf2 during atherogenesis may play a dual role including anti- and proatherogenic role, which is associated with the experimental model and its action on different
vascular beds.
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Fig. 8. Working model in this
project. In this model, Nrf2
plays an important role in
the occurrence of proliferative and atherosclerotic phenotype when CD38 gene was
silenced or deleted. CD38-derived enzyme product cADPR
and NAADP and associated
Ca2+ signaling mechanisms
are importantly implicated in
the control of Nrf2 activation
through NOX4-dependent O2·production.
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In this regard, it was reported that Nrf2 regulates VSMCs migration and neointimal
in vitro, and it alters the susceptibility of VSMCs to atherogenic stimuli [24]. However, a
direct role of Nrf2 in phenotypic switching of these VSMCs has not been determined. In
the present study, we determined the critical role of Nrf2 in phenotypic switching of CAMs
by knocking down its gene, which mimicked the effects of CD38 deficiency on phenotypic
switching in these CAMs. Moreover, we found that Nrf2 gene overexpression restored the
phenotypic switching in CD38-/- CAMs. These results support the view that Nrf2 functions
as a key regulator for CD38-dependent phenotypic switching in CAMs upon the atherogenic
stimulations. In previous studies, Nrf2 gene overexpression was also found to suppress
human or rabbit aortic smooth muscle cell proliferation in vitro [25]. In other studies,
the activation of Nrf2 has been shown to regulate the basal and inducible expression of
cytoprotective, detoxifying and antioxidant genes[26] and that Nrf2-ARE-oxidoreductase-1
(NQO1) pathway may importantly contribute to the inhibition of the major molecules that
lead to vascular damage and VSMCs proliferation and migration [10].
To further test how Nrf2 activity or translocation is altered by atherogenic stimuli in
CD38 deficient CAMs, we examined the role of CD38 associated with redox signaling. NOX1,
NOX2 and NOX4 were identified in vascular cells such as endothelial and smooth muscle
cells[27]. However, in our previous studies and by others demonstrated that NOX2 had no
significant action on extracellular and intracellular O2- production in response to ANG II
or oxotremorine [12, 28, 29]. In these studies, we have demonstrated that NOX1 primarily
contribute to extracellular O2·- production, but CD38 importantly controls NOX4-mediated
intracellular O2·-production in CAMs [12]. It is possible that O2-. derived from NOX4 contributes
to CD38-dependent Nrf2 activation in CAMs. Since our previous studies have also found that
CD38-regulated intracellular O2- production is primarily dependent on intracellular NOX4
activity [12], the present study addressed whether Nrf2-mediated phenotypic switching of
CD38-/- CAMs upon atherogenic stimuli is attributed to NOX4-dependent O2·- production. It
was found that 7-Ket failed to stimulate the production of O2-. in CD38-/- CAMs, but indeed
induced marked O2-. production and enhancement of Nrf2 activity in CD38+/+ CAMs. This O2production and consequent enhancement of Nrf2 activity in CD38+/+ CAMs were substantially
attenuated by NOX4 gene silencing, but not by NOX1 knocking down. These results provide
convincing evidence that NOX4 derived O2·- regulates Nrf2 activity and thereby determines
the phenotypic transition of CAMs into proliferative and sclerotic status. Although we did
not attempt to test how O2-. regulates Nrf2 activity, previous studies have shown that Nrf2
translocation to the nucleus and its activity are related to the action O2-. to target the Nrf2Keap1 complex [30, 31]. Under resting conditions, Keap1 plays a critical role in the control
of Nrf2 levels in the cells[32]. O2-. target the Nrf2-Keap1 complex, dissociating Nrf2 from
Keap1[33]. Stabilized Nrf2 is then translocated into the nucleus, where it transactivates
related target genes. In CAMs, this regulation of Nrf2 translocation or function is dependent
upon NOX4-dependent O2·- production, but not NOX1-derived O2- despite that NOX1 has
been shown to be enriched in membrane fraction to mainly produce extracellular O2-. [28].
Finally, we further explored the mechanism mediating NOX4-dependent O2- production
in CAMs upon atherogenic stimulations. Previous studies have shown that NOX4 activity
is sensitive to intracellular Ca2+ levels associated with cADPR-induced Ca2+ release from
ryanodine receptor, a Ca2+ channel on the SR membrane [34]. Therefore, it is possible that
CD38-derived cADPR production induces Ca2+ mobilization from the SR and thereby results in
local activation of NOX4 on the SR. The current study indeed demonstrated that cADPR from
CD38-cyclic ADP-ribosylcyclase was involved in 7-Ket-induced Ca2+ release. Furthermore,
cADPR-dependent Ca2+ release was shown to regulate Nrf2 activation. In addition, NAADP,
another product from CD38-cyclic ADP-ribosylcyclase was also involved in 7-Ket-induced
Ca2+ release to regulate Nrf2 activation. These findings provide direct evidence that cADPR
or NAADP-induced intracellular Ca2+ mobilization contributes to the activation of Nrf2 in
CAMs.
In conclusion, we demonstrated that upon atherogenic stimulation CD38 activity is
required for 7-Ket-induced O2·- production, which increases Nrf2 activity to maintain CAMs
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in a differentiated status. When CD38 gene expression and function are deficient, the Nrf2
activity is suppressed via NOX4-dependent O2- production leading to dedifferentiation of
CAMs.
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